EUS-guided drainage using this novel stent is feasible and the clinical results obtained are promising with a low major complication rate.

First experiences with ECS show good sensitivity rates even by blinded assessment for esophageal and colonic lesions. Sensitivity for neoplastic lesions in the stomach is lower because of gastric mucous secretion. Combining the endoscopic and cytoscopic appearance of the lesion may further enhance the diagnostic value of the method.

No abstract

No abstract